- Shares of Unilife (NASDAQ:UNIS) jump 13.1% AH after the company strikes an injectable drug delivery device supply agreement with Novartis for one of the latter's targeted early-stage pipeline drugs. Terms are confidential.
- Under the agreement, Unilife will supply Novartis with a customized syringe, needle, tubing, controller and pump device to administer a clinical trial drug into a targeted organ.